October 23, 2018 Dear CNF Partners, In 2014, the Harnett Grant was founded by Mr. Michael Harnett, as an enduring memorial to his nephew, Brendan Michael Harnett. Brendan was diagnosed with infantile spasms and passed away before his first birthday. The Child Neurology Foundation gratefully partners with the Harnett family again… Read More
CNF is proud to be co-convening the first of-its-kind All Stakeholder Access to Critical Therapies Summit with Global Genes on October 5, 2018 in Irvine, CA. The issue of access has huge implications for every health system stakeholder – patients, providers, payers, government, industry and investors – from ‘downstream’ at the point… Read More
The Child Neurology Foundation is pleased with the Federal Food & Drug Administration’s (FDA) approval Epidiolex ®, first prescription pharmaceutical formulation of highly-purified cannabidiol (CBD) and the first in its class of anti-epileptic drugs. It has been approved for the treatment of Lennox-Gastaut Syndrome and Dravet Syndrome – rare forms… Read More
